AOTMiT: Transparency Council on menopause, target import and reimbursement in off-label indications, among others

Agenda:

• 1. veoza (fezolinetantum) for the indication: treatment of moderate to severe vasomotor symptoms (VMS) associated with menopause

Decision-making problem: preparing a position on target imports (Article 39)

2.Milupa Basic F in indications:

• CACT deficit,
• VLCAD deficit,
• Lymphadenopathy (including conditions after cardiac surgery),
• abetalipoproteinemia,
• Lipid metabolism disorders (hypercholesterolemia and hypertriglyceridemia), lipoprotein lipase deficiency.
...

Content locked

To gain access to the complete English section of the Medexpress.pl, kindly reach out to us at [email protected].

If you already have an account, please log in